Acute Biphenotypic Leukemia (Leukemia, Mixed Cell)

Subscribe to Selected New Research on Acute Biphenotypic Leukemia

17 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.

Also Known As:

Leukemia, Mixed Cell; Leukemia, Biphenotypic, Acute; B and T Cell Acute Lymphoblastic Leukemia; B and T Cell Leukemia, Acute; Leukemia, Lymphocytic, Acute, Mixed Cell; Leukemia, Mixed, B and T Cell; Lymphocytic Leukemia, Acute, B and T Cell; Leukemias, Mixed-Cell; Mixed-Cell Leukemia; Mixed-Cell Leukemias; B- and T-Cell Acute Lymphoblastic Leukemia; B- and T-Cell Leukemia, Acute; Leukemia, Lymphocytic, Acute, Mixed-Cell; Leukemia, Mixed, B- and T-Cell; Leukemia, Mixed-Cell; Lymphocytic Leukemia, Acute, B- and T-Cell

Disease Context: Research Results

Neoplasms: 387349

Neoplasms by Histologic Type: 1

Leukemia: 32124

Lymphoid Leukemia: 1253

Acute Biphenotypic Leukemia: 17

Hemic and Lymphatic Diseases

Lymphatic Diseases: 1904

Lymphoproliferative Disorders: 2237

Lymphoid Leukemia: 1253

Acute Biphenotypic Leukemia: 17

Immune System Diseases: 1236

Immunoproliferative Disorders: 26

Lymphoproliferative Disorders: 2237

Lymphoid Leukemia: 1253

Acute Biphenotypic Leukemia: 17

Related Diseases

1.	Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
2.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
3.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
4.	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
5.	Leukemia

Experts

1.	Welch, Mary Alma: 1 article (11/2007)
2.	Schlette, Ellen: 1 article (11/2007)
3.	Giles, Francis J: 1 article (11/2007)
4.	Alvarado, Yesid: 1 article (11/2007)
5.	Swords, Ronan: 1 article (11/2007)
6.	Bruzzi, John: 1 article (11/2007)
7.	Miyoshi, I: 1 article (12/2006)
8.	Shimamura, Y: 1 article (12/2006)
9.	Daibata, M: 1 article (12/2006)
10.	Mizobuchi, M: 1 article (12/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Acute Biphenotypic Leukemia:

1.	Phosphotransferases (Kinase)IBA 06/01/2008 - "In this study, we found that AZD6244 (ARRY-142886), a novel inhibitor of MEK1/2 kinases, effectively inhibited the proliferation of acute biphenotypic leukemia MV4-11 and acute monocytic leukemia MOLM13 cells" Order ALL the reference details at left...
2.	AZD 6244IBA 06/01/2008 - "In this study, we found that AZD6244 (ARRY-142886), a novel inhibitor of MEK1/2 kinases, effectively inhibited the proliferation of acute biphenotypic leukemia MV4-11 and acute monocytic leukemia MOLM13 cells" Order ALL the reference details at left...
3.	Messenger RNA (mRNA)IBA 09/01/1993 - "We observed that expression of TdT mRNA and sterile transcription at both the Ig and TCR loci (transcription without gene rearrangement) was unexpectedly common in both acute biphenotypic leukemia and acute myelogenous leukemia (AML), and occurred in the absence of phenotypic lymphoid differentiation" 08/01/2003 - "Simultaneous novel BCR-ABL gene mutation and increased expression of BCR-ABL mRNA caused clinical resistance to STI571 in double-Ph-positive acute biphenotypic leukemia." 06/01/1998 - "Cyclin A1 mRNA was detectable in 11 of 11 patients with acute myeloid leukemia, three of three patients with acute biphenotypic leukemia, eight of eight patients with myelodysplastic syndrome, 59 of 69 patients with chronic myelogenous leukemia (CML) at diagnosis, 13 of 15 patients with CML in blastic transformation, 10 of 18 patients with chronic lymphocytic leukemia, two of nine patients with essential thrombocythemia, and only two of 10 patients with acute lymphoblastic leukemia (ALL) with both cyclin A1 RT-PCR positive ALL leukemias being undifferentiated relapses" Order ALL the reference details at left...
4.	CyclinsIBA 06/01/1998 - "Cyclin A1 mRNA was detectable in 11 of 11 patients with acute myeloid leukemia, three of three patients with acute biphenotypic leukemia, eight of eight patients with myelodysplastic syndrome, 59 of 69 patients with chronic myelogenous leukemia (CML) at diagnosis, 13 of 15 patients with CML in blastic transformation, 10 of 18 patients with chronic lymphocytic leukemia, two of nine patients with essential thrombocythemia, and only two of 10 patients with acute lymphoblastic leukemia (ALL) with both cyclin A1 RT-PCR positive ALL leukemias being undifferentiated relapses" Order ALL the reference details at left...
5.	Tryptophan (L-Tryptophan)FDA Link 02/01/1993 - "A 16-year-old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation" Order ALL the reference details at left...
6.	Reticulin (Reticular Fiber)IBA 12/01/2006 - "Bridging necrosis and reticulin bridging fibrosis induced by intrahepatic involvement of acute biphenotypic leukemia." Order ALL the reference details at left...
7.	ParaffinIBA 11/01/1994 - "All cases that were TdT-positive by immunofluorescence (41 of 42 "pre-B" and T-cell acute lymphoblastic leukemia, 2 of 5 acute myeloid leukemia, and 1 of 5 chronic myeloid leukemia in blast crisis) were also positive in paraffin sections" Order ALL the reference details at left...
8.	Immunoglobulins (Immunoglobulin)IBA 11/15/1991 - "The karyotypic abnormalities, t(9;22) and t(4;11), were noticed in acute biphenotypic leukemia, and were consistently associated with rearrangement at the immunoglobulin locus" Order ALL the reference details at left...
9.	Haloperidol (Haldol)FDA LinkGeneric 01/01/1984 - "Induction of monocytic-myelocytic mixed cell leukemias after the application of the neuroleptic haloperidol in mice]" Order ALL the reference details at left...
10.	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/15/1991 - "Surface marker analysis and karyotype distinguish acute biphenotypic leukemia from acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase." Order ALL the reference details at left...

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 05/01/1993 - "We report on the isolation of Candida krusei and Candida tropicalis from 17 blood cultures that were taken from a 67-year-old white man with a diagnosis of acute biphenotypic leukemia during a 2-week period of hospitalization for induction chemotherapy" 10/01/1989 - "In this paper is reported a case of acute biphenotypic leukemia who was treated by chemotherapy and pursued its effect by two color flow cytometry" 04/01/2004 - "An 18-year-old-male with acute biphenotypic leukemia developed massive gastrointestinal bleeding that was thought to be due to thrombocytopenia during chemotherapy-induced pancytopenia and did not respond to conventional therapy" 02/01/1993 - "A 16-year-old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation" Order ALL the reference details at left...
2.	Nutritional Support (Artificial Feeding) 02/01/1993 - "A 16-year-old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation" Order ALL the reference details at left...
3.	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/01/1996 - "We present a female patient who received an allogeneic bone marrow transplantation for primary refractory Philadelphia-positive acute biphenotypic leukemia" Order ALL the reference details at left...
4.	Transplantation (Transplant Recipients) 02/01/1993 - "A 16-year-old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Acute Biphenotypic Leukemia

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 0 Outcomes
Top 16 Key Drugs and Biologics
Top 4 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>